Date of event - estimated.The unique device identifier (udi) is unknown because the part number and lot number were not provided.Date of implant ¿ estimated.There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record and complaint history could not be conducted because the part and lot number were not provided.The reported patient effects of perforation and thrombosis, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use (ifu) are known adverse events associated with the use of a coronary scaffold in native coronary arteries.Based on the case information, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined and the treatment appears to be related to the circumstances of the procedure.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.Article title ¿coronary artery perforation after bioresorbable scaffold implantation treated with a new generation covered stent¿ oct insights.".
|
It was reported through a research article, in a general comment, identifying unknown absorb bio-resorbable vascular scaffold (bvs) as follows: use of the absorb bio-absorbable vascular scaffold (bvs) can lead to vessel perforation and thrombosis with potential treatment of prolonged balloon inflation, deployment of covered stents, insertion of pericardial drains, and heparin reversal.Details are listed in the article, titled coronary artery perforation after bio-resorbable scaffold implantation treated with a new generation covered stent¿ oct insights.Please see article for additional information.
|